PFE Oct 2024 34.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:31AM EDT. Market open.
| Previous close | 5.05 |
| Open | 5.05 |
| Bid | 4.85 |
| Ask | 6.10 |
| Strike | 34.00 |
| Expiry date | 2024-10-18 |
| Day's range | 5.05 - 5.05 |
| Contract range | N/A |
| Volume | |
| Open interest | 539 |
Yahoo FinanceNovavax's stock surges almost 300% in the past month
Novavax stock is soaring on news the FDA set a deadline by which to approve or reject its COVID-19 vaccine.
ZacksAbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
The late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with relapsed/refractory multiple myeloma who have received at least two lines of prior therapy.
Associated Press FinanceFDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. Moderna, Pfizer and Novavax all have tested doses updated to match the JN.1 variant that became dominant last winter. FDA’s advisers voted Wednesday that the next vaccine should come from the JN.1 “lineage” or family.
© 2024 Yahoo. All rights reserved.